Integrating QSAR modelling with reinforcement learning for Syk inhibitor discovery
Abstract Spleen tyrosine kinase (Syk) is a crucial mediator of inflammatory processes and a promising therapeutic target for the management of autoimmune disorders, such as immune thrombocytopenia. While several Syk inhibitors are known to date, their efficacy and safety profiles remain suboptimal,...
Saved in:
| Main Authors: | Maria Zavadskaya, Anastasia Orlova, Andrei Dmitrenko, Vladimir Vinogradov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Journal of Cheminformatics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13321-025-00998-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery
by: Rand Shahin, et al.
Published: (2025-12-01) -
Syk inhibitors reduce tau protein phosphorylation and oligomerization
by: Tomohisa Yamaguchi, et al.
Published: (2024-10-01) -
Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments
by: Duangjai Todsaporn, et al.
Published: (2025-01-01) -
Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
by: Bingjie Lin, et al.
Published: (2024-11-01) -
Ticagrelor inhibits the growth of lung adenocarcinoma by downregulating SYK expression and modulating the PI3K/AKT pathway
by: Yuanhong Song, et al.
Published: (2025-05-01)